BE study design issue [Design Issues]

posted by Dr_Dan  – 2019-12-18 14:04  – Posting: # 20992
Views: 601

Hi John
if the recommended dosage regimen of the IR as per product monograph IR is to be given every 4 hrs then this means that higher doses have either a safety issue or the dose/effect relationship is in disfavor of higher doses. In this case AUC alone does not matter. Consequently, a regulatory body will reject the study
Hope this helps
KR
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

Activity
 Admin contact
20,336 posts in 4,270 threads, 1,401 registered users;
online 10 (1 registered, 9 guests [including 8 identified bots]).
Forum time (Europe/Vienna): 10:48 UTC

Medical statistician: One who will not accept that Columbus discovered America…
because he said he was looking for India in the trial plan.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5